Literature DB >> 10851377

A three-sister sibship of Gerstmann-Sträussler-Scheinker disease with a CJD phenotype.

C Majtényi1, P Brown, L Cervenáková, L G Goldfarb, J Tateishi.   

Abstract

OBJECTIVE: To describe a rare phenotypic variant of P102L Gerstmann-Sträussler-Scheinker disease (GSS).
BACKGROUND: Classic GSS is characterized by an early age at onset, prominent cerebellar signs with a slowly evolving dementia, and a neuropathology including multifocal PrP-positive plaques and variable but usually modest spongiform change.
METHODS: Clinical, neuropathologic, immunohistochemical, and molecular genetic analysis of three sisters in a Hungarian family was performed.
RESULTS: The clinical course of all three sisters was indistinguishable from sporadic Creutzfeldt-Jakob disease (CJD). Neuropathologic examination revealed spongiform changes, PrP (prion)-positive unicentric "kuru" or multicentric plaques, and abundant beta-A4-positive senile plaques. Molecular genetic analysis of the PRNP gene showed the heterozygous codon P102L mutation of classic GSS, with the methionine encoding allele of a heterozygous codon 129 coupled to the mutant 102 allele.
CONCLUSION: The authors report the second recorded example of a sporadic CJD phenotype occurring in association with the P102L GSS genotype, and the first instance in which the phenotype was the rule rather than the exception, or was associated with prominent beta-A4 plaque formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851377     DOI: 10.1212/wnl.54.11.2133

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

2.  Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan.

Authors:  Nai-Fang Chi; Yi-Chung Lee; Yi-Chun Lu; Hsiu-Mei Wu; Bing-Wen Soong
Journal:  J Neurol       Date:  2009-08-21       Impact factor: 4.849

3.  Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Straussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family.

Authors:  Anna Rita Giovagnoli; Giuseppe Di Fede; Anna Aresi; Fabiola Reati; Giacomina Rossi; Fabrizio Tagliavini
Journal:  Neurol Sci       Date:  2008-11-21       Impact factor: 3.307

4.  Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.

Authors:  Emmanuel A Asante; Andrew Grimshaw; Michelle Smidak; Tatiana Jakubcova; Andrew Tomlinson; Asif Jeelani; Shyma Hamdan; Caroline Powell; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

5.  Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.

Authors:  Maya Higuma; Nobuo Sanjo; Katsuya Satoh; Yusei Shiga; Kenji Sakai; Ichiro Nozaki; Tsuyoshi Hamaguchi; Yosikazu Nakamura; Tetsuyuki Kitamoto; Susumu Shirabe; Shigeo Murayama; Masahito Yamada; Jun Tateishi; Hidehiro Mizusawa
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.

Authors:  Keisuke Ishizawa; Takashi Mitsufuji; Kei Shioda; Atsushi Kobayashi; Takashi Komori; Yoshihiko Nakazato; Tetsuyuki Kitamoto; Nobuo Araki; Toshimasa Yamamoto; Atsushi Sasaki
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.